StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.24+0.75 (+13.76%)

Close on Nov 20, 2026Market cap $116.75MP/E –Yield –

Trinity Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$6.02M. The highest annual figure on record is $20.58M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.02M–
FY2024Dec 31, 2024-$4.60M–
FY2023Dec 31, 2023-$12.36M–
FY2022Dec 31, 2022-$2.02M-117.7%
FY2021Dec 31, 2021$11.43M-44.5%
FY2020Dec 31, 2020$20.58M+523.7%
FY2019Dec 31, 2019$3.30M–
FY2018Dec 31, 2018-$299.00K-106.8%
FY2017Dec 31, 2017$4.41M-26.6%
FY2016Dec 31, 2016$6.01M-0.8%
FY2015Dec 31, 2015$6.06M–

More Trinity Biotech figures

See a number that looks wrong?